Cover Page

About tbcr

Manuscript Submission

AME Editing Service

Reprint & Permission

Advertising

Contact us

Meet the Professor 
We are on the right road | A brief history of breast cancer guidelines in China
Lili Liao
Translational Breast Cancer Research  
2021;
2:
26  
Editorial Commentary 
Neoadjuvant chemotherapy choices from population selection to regimen design: the St. Gallen International Expert Consensus Conference 2021
Qianqian Guo, Qianjun Chen
Translational Breast Cancer Research  
2021;
2:
25  
Editorial Commentary 
Updated interpretation for early breast cancer in The Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) guidelines
Bo Shen, Kun Wang, Zefei Jiang
Translational Breast Cancer Research  
2021;
2:
24  
Original Article 
Development and validation of a nomogram for predicting the status of estrogen receptor-low-positive breast cancer
Zhanli Jia, Shuyao Niu, Xinle Wang, Si Wu, Jinze Li, Mengxue Han, Yueping Liu
Translational Breast Cancer Research  
2021;
2:
23  
Review Article 
2021 updates in postoperative radiotherapy section of Chinese Society of Clinical Oncology Breast Cancer guideline
Lu Cao, Jun Zhang, Jiayi Chen, Zefei Jiang
Translational Breast Cancer Research  
2021;
2:
22  
Review Article 
St. Gallen 2021 Chinese expert perspective of optimal regional management
Binbin Cong, Yongsheng Wang
Translational Breast Cancer Research  
2021;
2:
21  
Review Article 
A review of endocrine therapy in early estrogen receptor-positive breast cancer by St. Gallen Breast Cancer Conference 2021
Yan Zhou, Jin Yang
Translational Breast Cancer Research  
2021;
2:
20  
Review Article 
Optimizing HER2-positive breast cancer therapy through neoadjuvant platforms: controversies and concepts
Shuang-Ling Wu, Ying-Ying Xu
Translational Breast Cancer Research  
2021;
2:
19  
Review Article 
Introduction to the key contents of the Chinese Society of Breast Surgery Practice Guideline 2021
Hongyu Xiang, Qian Liu, Yinhua Liu
Translational Breast Cancer Research  
2021;
2:
18  
Review Article 
Expert review on systemic treatment in the St. Gallen International Breast Cancer Conference 2021
Mingxi Lin, Yizi Jin, Jian Zhang
Translational Breast Cancer Research  
2021;
2:
17  
Case Report 
A case report of primary squamous cell carcinoma of the breast
Xiaoli Yao, Huihua He, Jingping Yuan, Feng Yao
Translational Breast Cancer Research  
2021;
2:
16  
Case Report 
T-DM1 for advanced breast cancer after multi-anti-HER2-target therapy: a case report
Langshuang Sun, Lu Gan, Tao Wang
Translational Breast Cancer Research  
2021;
2:
15  
Case Report 
Benefit with re-challenge of immune checkpoint inhibitors in patient with metastatic triple-negative breast cancer: a case report
Jinmei Zhou, Tao Wang, Li Bian, Jianbin Li, Zefei Jiang
Translational Breast Cancer Research  
2021;
2:
14  
Review Article 
Cyclin-dependent kinase 4 and 6 inhibitors at the crossroads: the combinational therapeutic strategies in breast cancer—a narrative review
Yiqi Yang, Sha Zhu, Ziyi Fu, Chunxiao Sun, Fan Yang, Tianyu Zeng, Yijia Hua, Shengnan Bao, Xian Gao, Xiang Huang, Wei Li, Yongmei Yin
Translational Breast Cancer Research  
2021;
2:
13  
Review Article 
Potential biomarkers of resistance to CDK4/6 inhibitors: a narrative review of preclinical and clinical studies
Weiyi Huang, Hongxia Wang
Translational Breast Cancer Research  
2021;
2:
12  
Original Article 
The role of FOXP3 of interstitial tissue in the pathogenesis of breast cancer
Yu-Juan Xiang, Man Feng, Li-Yuan Liu, Fei Wang, Li-Xiang Yu, Fei Zhou, Shu-Ya Huang, Chao Zheng, Chun-Miao Ye, Wen-Zhong Zhou, Geng-Shen Yin, Zhong-Bing Ma, Liang Li, Qiang Zhang, Qin-Ye Fu, Zhi-Gang Yu
Translational Breast Cancer Research  
2021;
2:
11  
Editorial 
How bone metastases can influence the management of breast cancer
T. John Martin
Translational Breast Cancer Research  
2021;
2:
10  
Case Report 
Aggressive breast fibromatosis with axillary accessory breast mastitis mimicking carcinoma: a case report
Yuhong Huang, Nan Shao, Huijuan Shi, Xiaoling Zhang, Yanling Zheng, Ying Lin
Translational Breast Cancer Research  
2021;
2:
8  
Review Article 
Bone metabolism and the development of denosumab: a narrative review
Xiaohui Niu, Hairong Xu
Translational Breast Cancer Research  
2021;
2:
7